1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.
    PLEASE HELP

Further insights into aspects of the illicit EU drugs market

Further insights into aspects of the illicit EU drugs market

  1. Docta
    This report provides the results from an analysis of characteristics and operations of the EU’s illicit drugs market as called for
    by the European Commission. The study is a follow-up of the earlier European Commission study presenting an analysis of
    the developments of the global illicit drugs market, the drug problems and drug policy responses in the period 1998-2007
    (Reuter and Trautmann 2009). The discussions of that study resulted in a number of further research questions considered
    important for future drug policy making in the EU. The questions regarded as most important by the European Commission
    have been put together in a call for a further analysis of the EU illicit drugs market and responses to it, focusing on a number
    of aspects in the following four areas:
    1. An analysis of specific characteristics, mechanisms and factors that govern the EU illicit drugs market, including a conceptual framework for thinking about the structure of the supply side of that market, an assessment whether there have been significant shifts in how drugs are supplied in the EU and an assessment of the extent to which drug suppliers are involved in different drugs and other criminal activities.
    2. A detailed analysis of the size and share of the EU illicit drug market, providing an estimate of the volume of the ‘EU market’ in illicit drugs (production and trafficking) and of the profits generated by this market, analysing whether the EU drugs market is more supply or demand driven and exploring various aspects of drug use: user types, availability and consumption estimates.
    3. A detailed analysis of a number of potential policy impacts on the EU drug market(s) in recent years, assessing the impact of opioid substitution treatment (OST) on the European heroin market and the impact of policy changes on two EU drug markets.
    4. Scanning the future – exploring expert views on future key trends of the illicit drug markets and policy responses in the EU.